Course Details
- TOP
- Regular Graduate Course
-
Cancer Specialist Training Course: Personalized Medicine Based on Cancer Genes
| Name of University | Kanazawa Medical University | ||||||
|---|---|---|---|---|---|---|---|
| Course name | Cancer Specialist Training Course: Personalized Medicine Based on Cancer Genes(Regular Graduate Course) | ||||||
| Target Occupation | Clinical Doctors | ||||||
| Length of study (period) | 4 years | ||||||
| Human resources to be trained | To train medical oncology specialists who understand cancer genome information essential for the development and progression of cancer and who can provide advice to medical professionals regarding the results of cancer gene panel tests based on pathological diagnosis. | ||||||
| Cooperation with professional qualifications related to cancer | Kanazawa Medical University Hospital is designated as a regional base hospital for cancer treatment. It is also accredited as a training facility for board-certified physicians and specialists in each of the basic medical specialties recognized by the Japanese Association of Medical Specialties. In this educational course, emphasis is placed on the training of subspecialists such as cancer pharmacotherapy specialists (Japanese Society of Clinical Oncology), clinical genetic specialists (Japanese Society of Human Genetics and Japanese Society of Genetic Counseling), and molecular pathologists (Japanese Society of Pathology). | ||||||
| Characteristics of educational content | In this era, it is essential for the next generation of cancer care providers to understand cancer genome medicine and the results of genome analysis, and to provide advice to medical professionals. | ||||||
| Guidance system | The program will be taught by multiple faculty members, including cancer pharmacotherapy specialists, molecular pathologists, and specialists familiar with familial tumors as well as genetics diagnosis and genetic counseling. | ||||||
| Career path of graduates | The physicians trained in this course will contribute to cancer care at regional flagship hospitals as the next generation of cancer specialist leaders who understand and practice cancer genomics and have the outstanding knowledge and experience to promote collaboration in team medicine consisting of multiple professions. | ||||||
| Number of students accepted | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | Total |
| 1 | 1 | 1 | 1 | 1 | 5 | ||
| Acceptance Goals | The goal is to assign at least one oncologist practicing cancer genome medicine to each of the five cancer base hospitals in the Hokuriku and Shinshu regions. Five specialists will be accepted over a five-year period starting in FY2024. In addition, from the perspective of the number of applicants for graduate school, the target number of acceptance is set at one, since one person is expected to complete the specialist training course each fiscal year. | ||||||
For healthcare professionals, other graduate students, non-degree students, and the general public
Incentive Courses